Cargando…
Hemospray for recurrent esophageal band ulcer bleeding
Rebleeding after initially successful endoscopic variceal ligation (EVL) occurs in 20-60% of patients, most commonly from band ulcers, and is associated with 20-50% mortality. Although band ulcer bleeding has been treated in a number of different ways, no single therapeutic intervention has shown a...
Autores principales: | Sanglodkar, Uday A., Jothimani, Dinesh, Rela, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865909/ https://www.ncbi.nlm.nih.gov/pubmed/29594199 http://dx.doi.org/10.5114/ceh.2018.73668 |
Ejemplares similares
-
Hemospray hemostasis in bleeding diffusely ulcerated esophagus
por: Tang, Shou-jiang, et al.
Publicado: (2019) -
Hemospray for Life-Threatening Ulcer Bleeding: First Case Report in the United States
por: Sargon, Peter J., et al.
Publicado: (2013) -
Hemospray as the Initial Treatment of a Lower Gastrointestinal Bleed Resulting from Stercoral Ulceration
por: Woo, Matthew, et al.
Publicado: (2018) -
Severe Jaundice in a COVID-19 Patient–Virus or Drug?
por: Jothimani, Dinesh, et al.
Publicado: (2021) -
Comparison of Hemospray(®) and Endoclot(™) for the treatment of gastrointestinal bleeding
por: Vitali, Francesco, et al.
Publicado: (2019)